May Orfali

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by May Orfali:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 10,000 $7,500 $0.7500 18 Feb 2022 Direct

Insider Reports Filed by May Orfali

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588922001633-orfali-may-2022-02-18 Sigilon Therapeutics, Inc. 18 Feb 2022 1 +$14,800 4 CHIEF MEDICAL OFFICER 22 Feb 2022, 16:00
/report/000141588922000196-orfali-may-2022-01-03 Sigilon Therapeutics, Inc. 03 Jan 2022 1 +$30,300 4 CHIEF MEDICAL OFFICER 04 Jan 2022, 15:15
/report/000141588921005621-orfali-may-2021-12-01 Sigilon Therapeutics, Inc. 01 Dec 2021 1 $0 4 CHIEF MEDICAL OFFICER 01 Dec 2021, 15:45
/report/000141588921005619-orfali-may-2021-11-29 Sigilon Therapeutics, Inc. 29 Nov 2021 0 $0 3 CHIEF MEDICAL OFFICER 01 Dec 2021, 15:44